Madrigal Pharmaceuticals, Inc.
NASDAQ:MDGLBiotechnology
Healthcare
$398.08 -0.27%
-$1.33 today
- Market cap
- $9.25B
- Beta
- -1.06
- P/E (TTM)
- -46.9
- EPS (TTM)
- -$10.66
52W Low $276.67High $615.00
Volume 0.64M
Average 0.31M
News
For Madrigal Pharmaceuticals, Inc., read summarized stories built from several publishers and recent headlines with links to the original coverage.
Stories
All market newsNo stories for MDGL yet. A story appears once at least three publishers cover the same event.
More headlines
Recent coverage that has not been summarized. Links open the publisher's site.
- Kaplan Fox & Kilsheimer LLP is Investigating Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) for Potential Securities Law Violations
GlobeNewsWire
- Kaplan Fox & Kilsheimer LLP Alerts Investors of Madrigal Pharmaceuticals, Inc. (MDGL) to an Investigation of Potential Securities Law Violations
Newsfile Corp
- MDGL Investigation Reminder: Madrigal Pharmaceuticals, Inc. Investors are Encouraged to Contact Kessler Topaz Meltzer & Check, LLP
PRNewsWire
- Madrigal Pharmaceuticals, Inc. (MDGL) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Seeking Alpha
- Kaplan Fox Notifies Madrigal Pharmaceuticals, Inc. (MDGL) Investors of a Securities Investigation into the Company
Newsfile Corp
- Kaplan Fox Reminds Investors of Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) to Contact the Firm Regarding an Investigation of Potential Securities Law Violations
GlobeNewsWire
Continue the stock analysis
Jump to another research area for this company.